With primary focus on those battling addictions and living with neurological disorders, Chrono Therapeutics is focused on improving clinical outcomes for patients battling addictions and living with neurological disorders using the firm's proprietary Digital Patch platform. Offering a new era of transdermal drug delivery designed to meet each patient's individual needs the efort is to integrate timed drug delivery with personalized, mobile-phone-based digital support and unique data analytics to maximize compliance. Outcome: to enable patients to manage hard to treat conditions and optimize clinical outcomes. With seeveral inplace programs in active development that address significant market opportunities with unmet (or poorly) met needs, the approach is to have each program leverages medications that readily cross the skin. In addition to the programs currently in development for smoking cessation, Parkinson's Disease dyskinesia and prescription opioid dependence, the firm's discovery pipeline is robust, with a number of CNS indications under evaluation that would benefit from a therapeutic combined with behavioral and compliance support
